Summary: Type I collagen is the main type found in mineralized bone. Specific radioimmunoassay for the crosslinked carboxyterminal telopeptide of type I collagen allows assessing the degradation of type I collagen in serum samples.
Introduction
Type I collagen is the most abundant form of collagen collagen. The telopeptide is liberated during degradain bone, forming 90% of the organic matrix. It is synthe-tion of collagen fibrils of bone and can be estimated in sized by osteoblasts and is formed as a large precursor blood samples (2, 3) . Many diseases, e. g. rheumatoid protein, type I procollagen (1, 2) . In type I collagen of arthritis, multiple myeloma, bone metastases in pabones part of the mature cross-links is formed from two tients suffering from cancer of the prostate, and osoriginal hydroxylysine residues and one lysine residue teopenia among premature infants are associated with (deoxypyridinoline) or from three hydroxylysine resi-increased degradation of type I collagen in the skeleton dues (pyridinoline). The hydroxylysine residues can be (2, (6) (7) (8) . Furthermore, long-term suppressive thyroxglycosylated. Similar structures occur in other collagen ine treatment in patients with thyroid carcinoma seems types, particularly in the type II collagen of cartilage, to accelerate bone collagen degradation and carries a which is rich in pyridinoline (3) . When the collagen mat-risk of osteoporosis (9) . Type I collagen telopeptide rix is degraded, both kinds of cross-links are released concentration was also found to be correlated with into the circulation and excreted in urine. Deoxypyridi-bone resorption rate, measured histomorphometrically noline is found almost exclusively in bone, whereas pyr- (3, 8, 10) . idinoline is located in collagen fibrils of bone as well as fa ±Q experimental study per f ormed on the rats fed a cartilage. The measurements of deoxypyridinoline and bw caldum and vitamm D . deficient diet for 21 p yridinolme in urine are considered to be indices of the ^ increased resorptive processes concomit ant with a activity of bone collagen degradation (4, 5) . defect ώ ±Q process Qf bone formation ^ its ^Â nother simple and quantitative test of type I collagen zation of the alveolar process in histologic examinations degradation is based on the analysis of the concentra-were observed. Densitometric analysis showed the detion of carboxyterminal telopeptide region of type I creased density of the whole bony system of these ani-mals and finally biochemical examinations showed hypocalcaemia together with the increase in alkaline phosphatase activity (11) .
The aim of the present investigation was to determine serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen in rats fed a low calcium and vitamin D-deficient diet.
Materials and Methods

Animals and diets
Young male Wistar rats (body weight 106 ± 3.6 g, 30 days old) were the experimental animals. At the beginning of the experimental period, the rats were divided into two groups with 10 animals in each group: (1) control animals -group B -were fed a diet meeting the nutritional needs of the rats (12 g/kg Ca, 2250 I.U./kg vitamin Da); (2) test animals -group A -were fed a deficient diet (0.4 g/kg Ca, no vitamin D), but otherwise equal to the diet fed the first group. The animals were allowed free access to water. The diet was based on the original recipe made by Engstr m et al. (12) .
Specimen collection and storage
Blood samples were drawn from each animal by intravenous puncture of the jugular vein on days 14 and 21 of the experiment. Serum samples were separated and stored at -30 °C until they were assayed. At the end of the experiment (day 21), the animals were killed by exsanguination under anaesthesia with sodium barbital (40 mg/kg intraperitoneal). I-labelled RAT-ICTP. After a 2 hour incubation at 37 °C separation reagent was mixed thoroughly by gentle inversion and then added. Tubes were allowed to stand for 30 minutes at room temperature and then were centrifuged for 30 minutes. The supernatant was then removed and the sediment containing the precipitated antibody-antigen complex was counted in a gamma counter (according to Orion Diagnostica Instruction Kit).
In our laboratory, the intra-assay precision ranged from 2.8% to 6.2%; inter-assay precision ranged from 4.1% to 7.9%; the sensitivity of the assay was 0.5 μ^. The concentration of the cross-linked carboxyterminal telopeptide of type I collagen in serum was expressed in μ^.
Determination of total calcium concentration in serum Total calcium concentration in sera of the rats from both groups were determined by standard colorimetric methods using a Cobas Mira analyzer, Hoffmann LaRoche (Switzerland).
Statistics
The data obtained from biochemical study were presented as the arithmetical mean with the standard deviation (x ± SD) for each group of 10 rats (n = 10). A comparison between the two groups was performed with the unpaired Student's t test. Comparisons between the mean values of serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen obtained on days 14 and 21 of the experiment within one group were performed with the paired Student's test. Statistically significant difference was considered at p <0.05.
Results
The results of biochemical analysis of total calcium concentration in sera of the rats fed a low calcium and vitamin D-deficient diet had been presented previously (6) . The mean value of total calcium concentration in sera of the test animals obtained on day 14 was 1.84 ± 0.05 mmol/1, while in the control animals it was 2.51 ± 0.12 mmol/1. The differences between the values were statistically significant (p < 0.001). On day 21, the mean value of total calcium concentration in sera of the test animals was 1.78 ±0.1 mmol/1 and was lower than that obtained in the control rats -2.53 ±0.11 mmol/ 1. The differences between the values were statistically significant (p < 0.001).
The concentration of the cross-linked carboxyterminal telopeptide of type I collagen on days 14 and 21 of the experiment are shown in table 1. The mean concentration of the cross-linked carboxyterminal telopeptide of type I collagen in serum on day 14 was significantly higher in the rats fed a low calcium and vitamin Ddeficient diet (p < 0.001) in comparison to the mean value obtained in the control animals. At the end of the experiment (day 21), the concentration of the carboxyterminal telopeptide of type I collagen in serum was still Tab. 1 Mean values of serum carboxyterminal telopeptide of type I collagen concentration in the test (group A) and the control (group B) animals (days 14 and 21). Values are the mean with the standard deviation (x ± SD) for the groups of 10 animals each (n = 10) 
Discussion
Bone remodelling first comprises a phase of osteoclast activation and osteoclastic bone resorption with the formation of a resorption cavity. Subsequently, osteoblasts synthesize type I collagen. Then the osteoid matrix thus formed undergoes mineralization and self-repair of skeletal tissue occurs (2) . A dietary calcium and vitamin Ddeficiency in rats enhances osteoclastic bone resorption concomitant with a defect in bone matrix formation and its mineralization as observed in our previous histologic examinations. We observed these morphological changes in the alveolar process of the rat's maxilla since this tissue is characterized by the high bone turnover (11).
Type I collagen telopeptide concentration was found to be correlated with cancellous bone resorption rate, measured by histomorphometry, and therefore is regarded as a specific marker of bone resorption (8, 10).
Elomaa et al. (2) studied the serum concentration of carboxyterminal propeptide of type I procollagen and carboxyterminal telopeptide of type I collagen in order to follow bone turnover and evaluate treatment response in multiple myeloma, which is a good model disease for excessive osteolysis. The study indicated that serum concentration of carboxyterminal telopeptide of type I collagen correlated with the number of osteolytic lesions. The lack of correlation between carboxyterminal telopeptide of type I collagen and carboxyterminal propeptide of type I procollagen proves, in the authors' opinion, imbalanced bone turnover and suggests unchanged and even depressed bone formation in multiple myeloma.
Eriksen at al. (10) , using the method of calcium kinetics and dynamic histomorphometry, found a significant correlation between serum concentration of carboxyterminal telopeptide of type I collagen and bone resorption in patients with low and high bone turnover rates.
Mora et al. (8) stated that carboxyterminal telopeptide of type I collagen is a useful marker of bone modelling in osteopenia, a well-recognized disorder of bone metabolism among premature infants. The authors studied bone formation and degradation through the measurements of three indices: osteocalcin, carboxyterminal propeptide of type I procollagen and carboxyterminal telopeptide of type I collagen in premature infants at the age of 4 weeks in comparison to full-term subjects. The results showed significantly higher osteocalcin levels in full-term infants, while the bone resorption marker, carboxyterminal telopeptide of type I collagen, was significantly higher in premature infants than in full-term ones.
Carboxyterminal propeptide of type I procollagen did not differ between the two groups. The authors conclude that in premature infants at the age of 4 weeks, there appeared a low osteoblastic activity and enhanced bone degradation compared with that of full-term controls. The imbalance of bone modelling could be the cause of the reduced bone mineralization found in preterm infants.
Hakala et al. (6) assessed the extent and clinical significance of serum carboxyterminal telopeptide of type I collagen in rheumatoid arthritis. It has been proven by the authors that the elevated serum concentration of carboxyterminal telopeptide of type I collagen is common in rheumatoid arthritis and associated with the signs of aggressive disease.
To the contrary, Garnero et al. (13) performed studies on a group consisting of late postmenopausal osteoporotic women and found no statistically significant differences in the values of serum concentration of carboxyterminal telopeptide of type I collagen and carboxyterminal propeptide of type I procollagen in comparison with the group of controls, although other biochemical markers of bone metabolism, e. g. serum total and serum intact osteocalcin concentration, serum bone alkaline phosphatase activity and urinary total pyridinoline and deoxypyridinoline, indicated increased bone turnover and, as determined by dual energy X-ray absorptiometry showed decreased bone mass. The authors explain that a possible reason for inability of serum carboxyterminal telopeptide of type I collagen to detect increase in bone turnover is that the circulating carboxyterminal telopeptide of type I collagen may not reflect the true collagen degradation rate, but may reflect other aspects of connective tissue turnover. Delmas (14) suggests that serum carboxyterminal telopeptide of type I collagen is an index of collagen turnover, but not a specific marker of bone resorption.
The results of our study showed the increased values of serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen in the rats fed a low calcium and vitamin D-deficient diet in comparison to the values obtained in the control animals. Considering the morphological changes of the alveolar process of the maxilla and densitometric data described previously (11) we suggest that the elevated serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen correlates with the increased bone resorption and decreased density of the whole bony system in the rats fed a low calcium and vitamin D-deficient diet. More-over, the elevated serum concentration of the crosslinked carboxyterminal telopeptide of type I collagen correlates with the decreased levels of total calcium in sera of these animals.
In conclusion, dietary calcium and vitamin D-deficiency in rats produces hypocalcaemia together with the increased serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen.
